Lipitor news from FiercePharma
NewsWill DTC hearing lead to new regulation?
Will today's Congressional hearing on drug ads lead to new legislation? That's what Michigan Read more...
New Canadian rules to delay big generics
Generics makers are up in arms over proposed patent rules in Canada. The drug copycats say the rules will delay generic Lipitor and several other blockbusters by as much as two years. (Can you hear Read more...
Make generic-switching bonuses illegal?
Should insurers be allowed to reward docs who switch patients to generics? That debate is going public in Colorado, where legislators have proposed a bill that would prohibit the practice. On the Read more...
Office upholds Pfizer's Lipitor patent
Pfizer is breathing a big sigh of relief. The U.S. Patent & Trademark Office has said it will confirm the drugmaker's basic patent on the blockbuster Lipitor drug. The office had been Read more...
Crestor aces huge study, says AZ
Some cholesterol med-makers do have reason to rejoice today. AstraZeneca stopped a study of its blockbuster Crestor, saying the pill had already demonstrated clear benefits over placebo. The Read more...
Pfizer sues for Lipitor protection till 2016
Pfizer is hitting back at would-be Lipitor Read more...
Shire stock jumps on Pfizer rumors
Less than 10 days after CEO Jeffrey Kindler pooh-poohed big acquisitions, U.K. markets are aswirl with Read more...
Pfizer's Kindler can't quash mega-deal talk
Kids who want ice cream won't take no for answer. Neither, apparently, will some Pfizer investors, who are clamoring again for a big acquisition just days after CEO Jeff Kindler said he wouldn't play Read more...
Analysts not impressed with Pfizer
Investors and analysts are none too impressed with Pfizer's new strategies as outlined by CEO Jeffrey Kindler and other execs during an annual Wall Street update yesterday. The stock fell to within Read more...
Is Pfizer's CEO as bold as promised?
Like natives encountering a strange explorer in an old B movie, investors hailed Jeffrey Kindler (photo) when he was Read more...
| Press ReleasesPRESS RELEASE: Spanish Appellate Court Rules in Pfizer’s Favor, Upholds Lipitor Patent Spanish Appellate Court Rules in Pfizer’s Favor, Upholds Lipitor Patent NEW YORK -- Pfizer Inc said today that the Court of Appeal of Barcelona has upheld the company's enantiomer patent covering Read more... PRESS RELEASE: Canadian Court Finds Infringement of Lipitor Crystal Form Patent Canadian Court Finds Infringement of Lipitor Crystal Form Patent NEW YORK -- Pfizer Inc said today that the Canadian Federal Court in Toronto has ruled that Pfizer’s patent covering a crystalline Read more... PRESS RELEASE: Canadian Court Favors Ranbaxy, Dismisses Pfizer's Application on Atrovastatin Patent CANADIAN FEDERAL COURT FAVOURS RANBAXY DISMISSES PFIZER'S APPLICATION ON ATORVASTATIN PATENT CA 2,220,455 Gurgaon, Haryana, India, Princeton, New Jersey, USA - September 13, 2007 Ranbaxy Read more... |
Get more Lipitor coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight